Wang Y, Liu Z, Lin T-M, Chanana S, Xiong MP. Nanogel-DFO conjugates as a model to investigate pharmacokinetics, biodistribution, and iron chelation in vivo. Int J Pharm. 2018;538(1–2):79–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Z, Qiao J, Nagy T, Xiong MP. ROS-triggered degradable iron-chelating nanogels: safely improving iron elimination in vivo. J Control Release. 2018;283:84–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Royal CD, Babyak M, Shah N, Srivatsa S, Stewart KA, Tanabe P, et al. Sickle cell disease is a global prototype for integrative research and healthcare. Adv Genet. 2021;2(1):e10037.

Article  PubMed  PubMed Central  Google Scholar 

Farshadpour F, Taherkhani R, Farajzadeh H. Hepatitis B infection among β-thalassemia major patients in Bushehr province of southern Iran. J Immunoassay Immunochem. 2023;44(2):147–61.

Article  CAS  PubMed  Google Scholar 

ADMINISTRATION USFD: FDA approves first gene therapies to treat patients with sickle cell disease. https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease (2023). Accessed 08 Dec 2023.

Sheridan C. The world’s first CRISPR therapy is approved: who will receive it? Nat Biotechnol. 2024;42(1):3–4.

Article  CAS  PubMed  Google Scholar 

Vakulskas CA, Behlke MA. Evaluation and reduction of CRISPR off-target cleavage events. Nucleic Acid Ther. 2019;29(4):167–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Z, Simchick GA, Qiao J, Ashcraft MM, Cui S, Nagy T, et al. Reactive oxygen species-triggered dissociation of a polyrotaxane-based nanochelator for enhanced clearance of systemic and hepatic iron. ACS Nano. 2020;15(1):419–33.

Article  PubMed  PubMed Central  Google Scholar 

Hershko C, Abrahamov A, Konijn A, Breuer W, Cabantchik I, Pootrakul P, et al. Objectives and methods of iron chelation therapy. Bioinorg Chem Appl. 2003;1(2):151–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pawlaczyk M, Schroeder G. Deferoxamine-modified hybrid materials for direct chelation of Fe (III) ions from aqueous solutions and indication of the competitiveness of in vitro complexing toward a biological system. ACS Omega. 2021;6(23):15168–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salimi A, Zadeh BSM, Kazemi M. Preparation and optimization of polymeric micelles as an oral drug delivery system for deferoxamine mesylate: in vitro and ex vivo studies. Res Pharm Sci. 2019;14(4):293.

Article  PubMed  PubMed Central  Google Scholar 

Rassu G, Soddu E, Cossu M, Brundu A, Cerri G, Marchetti N, et al. Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate. J Control Release. 2015;201:68–77.

Article  CAS  PubMed  Google Scholar 

Poggiali E, Cassinerio E, Zanaboni L, Cappellini MD. An update on iron chelation therapy. Blood Transfus. 2012;10(4):411.

PubMed  PubMed Central  Google Scholar 

Farr AC, Xiong MP. Challenges and opportunities of deferoxamine delivery for treatment of Alzheimer’s disease, Parkinson’s disease, and intracerebral hemorrhage. Mol Pharm. 2020;18(2):593–609.

Article  PubMed  PubMed Central  Google Scholar 

Neufeld EJ. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood. 2006;107(9):3436–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu L, Yang S, Chen F, Cheng K-W. Hyaluronic acid–zein core-shell nanoparticles improve the anticancer effect of curcumin alone or in combination with oxaliplatin against colorectal cancer via CD44-mediated cellular uptake. Molecules. 2022;27(5):1498.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aguilera-Garrido A, Molina-Bolívar J, Gálvez-Ruiz M, Galisteo-González F. Mucoadhesive properties of liquid lipid nanocapsules enhanced by hyaluronic acid. J Mol Liq. 2019;296:111965.

Article  CAS  Google Scholar 

Zhang M, Asghar S, Jin X, Hu Z, Ping Q, Chen Z, et al. The enhancing effect of N-acetylcysteine modified hyaluronic acid-octadecylamine micelles on the oral absorption of paclitaxel. Int J Biol Macromol. 2019;138:636–47.

Article  CAS  PubMed  Google Scholar 

Bhujbal S, Dash AK. Metformin-loaded hyaluronic acid nanostructure for oral delivery. AAPS PharmSciTech. 2018;19:2543–53.

Article  CAS  PubMed  Google Scholar 

Wu H, Guo T, Nan J, Yang L, Liao G, Park HJ, et al. Hyaluronic-acid-coated chitosan nanoparticles for insulin oral delivery: fabrication, characterization, and hypoglycemic ability. Macromol Biosci. 2022;22(7):2100493.

Article  CAS  Google Scholar 

Zhao L, Ding J, He P, Xiao C, Tang Z, Zhuang X, et al. An efficient pH sensitive oral insulin delivery system enhanced by deoxycholic acid. J Control Release. 2011;152:e184–6.

Article  CAS  PubMed  Google Scholar 

Lei C, Liu X-R, Chen Q-B, Li Y, Zhou J-L, Zhou L-Y, et al. Hyaluronic acid and albumin based nanoparticles for drug delivery. J Control Release. 2021;331:416–33.

Article  CAS  PubMed  Google Scholar 

Tian H, He Z, Sun C, Yang C, Zhao P, Liu L, et al. Uniform core–shell nanoparticles with thiolated hyaluronic acid coating to enhance oral delivery of insulin. Adv Healthcare Mater. 2018;7(17):1800285.

Article  Google Scholar 

Yegappan R, Selvaprithiviraj V, Mohandas A, Jayakumar R. Nano polydopamine crosslinked thiol-functionalized hyaluronic acid hydrogel for angiogenic drug delivery. Colloids Surf, B. 2019;177:41–9.

Article  CAS  Google Scholar 

Zhu J, Tang X, Jia Y, Ho C-T, Huang Q. Applications and delivery mechanisms of hyaluronic acid used for topical/transdermal delivery–a review. Int J Pharm. 2020;578:119127.

Article  CAS  PubMed  Google Scholar 

Buckley C, Murphy EJ, Montgomery TR, Major I. Hyaluronic acid: a review of the drug delivery capabilities of this naturally occurring polysaccharide. Polymers. 2022;14(17):3442.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Meng S, Zhou X, Gao Z, Piao MG. pH-Responsive and mucoadhesive nanoparticles for enhanced oral insulin delivery: the effect of hyaluronic acid with different molecular weights. Pharmaceutics. 2023;15(3):820.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang P, Yang C, Liu J, Wang W, Guo S, Li J, et al. Improving the oral delivery efficiency of anticancer drugs by chitosan coated polycaprolactone-grafted hyaluronic acid nanoparticles. J Mater Chem B. 2014;2(25):4021–33.

Article  CAS  PubMed  Google Scholar 

Lu Y, Wu L, Lin M, Bao X, Zhong H, Ke P, et al. Double layer spherical nanoparticles with hyaluronic acid coating to enhance oral delivery of exenatide in T2DM rats. Eur J Pharm Biopharm. 2023;191:205–18.

Article  CAS  PubMed  Google Scholar 

de Souza AB, Chaud MV, Santana MHA. Hyaluronic acid behavior in oral administration and perspectives for nanotechnology-based formulations: a review. Carbohyd Polym. 2019;222:115001.

Article  Google Scholar 

Huang G, Huang H. Application of hyaluronic acid as carriers in drug delivery. Drug Deliv. 2018;25(1):766–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samstein RM, Perica K, Balderrama F, Look M, Fahmy TM. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials. 2008;29(6):703–8.

Article  CAS  PubMed  Google Scholar 

Li Z, Zhang M, Liu C, Zhou S, Zhang W, Wang T, et al. Development of liposome containing sodium deoxycholate to enhance oral bioavailability of itraconazole. Asian J Pharm Sci. 2017;12(2):157–64.

Article  PubMed  Google Scholar 

Stojančević M, Pavlović N, Goločorbin-Kon S, Mikov M. Application of bile acids in drug formulation and delivery. Front Life Sci. 2013;7(3–4):112–22.

Article  Google Scholar 

Hanafi NI, Mohamed AS, Sheikh Abdul Kadir SH, Othman MHD. Overview of bile acids signaling and perspective on the signal of ursodeoxycholic acid, the most hydrophilic bile acid, in the heart. Biomolecules. 2018;8(4):159.

Article  PubMed  PubMed Central  Google Scholar 

Roda A, Minutello A, Angellotti M, Fini A. Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC. J Lipid Res. 1990;31(8):1433–43.

Article  CAS  PubMed  Google Scholar 

Nurunnabi M, Khatun Z, Revuri V, Nafiujjaman M, Cha S, Cho S, et al. Design and strategies for bile acid mediated therapy and imaging. RSC Adv. 2016;6(78):73986–4002.

Article